Meeting
2022 ASCO Annual Meeting
Whole transcriptomic analysis of HR+ breast cancer in Black women classified as basal-type by BluePrint.
Authors
Sonya A. Reid
Vanderbilt University Medical Center, Nahsville, TN
Sonya A. Reid , Tuya Pal , Xiao-Ou Shu , Ann Tezak , Kent Hoskins , Dipali Sharma , Jennifer Wei , Yen Huynh , Josien Haan , Shiyu Wang , Andrea Menicucci , Patricia Dauer , M. William Audeh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03053193
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 517)
DOI
10.1200/JCO.2022.40.16_suppl.517
Abstract #
517
Poster Bd #
289
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Impact of race on BluePrint genomic subtyping in HER2+ breast cancer.
First Author: Sonya A. Reid
Poster
2022 ASCO Annual Meeting
Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC).
First Author: David B. Page
Poster
2020 ASCO Virtual Scientific Program
Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in Caucasian, African American, and Latin American patients.
First Author: Virginia G. Kaklamani
Poster
2024 ASCO Breakthrough
Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
First Author: Evelyn Tan